Our facilities are regularly inspected by multiple regulatory authorities, ensuring all sites operate to the highest international standard of quality, safety, and environmental control.

We have a dedicated project management team, recognizing the diversity of our clients by deploying a flexible approach to all projects, with local representation and support in all territories. This allows intimate cooperation with all customers during all stages of project reviews, along with bespoke and customized solutions suited for each case and scenario.

Dishman Carbogen Amcis Ltd invest in strong, tenured leadership at both corporate and local levels, operating under strictly robust and secure protection policies that assure protection of our clients' Intellectual Property (IP) at every stage of the management process.

Our Supply Chain Management team sources raw materials, facilitating secure transfers, managing storage, and a rapid supply; ensuring timely delivery to all of our customers while maintaining full compliance with all safety and regulatory standards.

The Dishman Carbogen Amcis Ltd global supply chain presence, backed by nearly 40 years of experience, helps us secure materials within prescribed times and at the best value.

With local teams in India, the United Kindom, Switzerland, China, and Holland, we can ensure understanding and compliance with the often complex regional requirements & local storage - giving flexibility in deliveries and the reduction of cross border customs costs while ensuring our clients' materials arrive where and when they are needed.

Welcome to Dishman Carbogen Amcis Ltd!

We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The Dishman Group continually invests in the pharmaceutical industry, ensuring our businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future. Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. We strongly believe that our business is successful only when our customers are successful.

The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.

We have been supporting the pharmaceutical and healthcare industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to market while improving the lives of their patients across the world.

Our objective is to help our customers create a better world as the partner of choice to develop and manufacture complex and challenging substances, highly potent active ingredients, and breaking new ground with innovative vitamin, healthcare, and industrial products.

Dishman Carbogen Amcis Ltd focusses on the reduction of operational risk in chemical development and commercial manufacturing by:

•• Minimising the time associated with drug development
•• Decreasing the risks associated with drug development
•• Providing long-term and value-added contract manufacturing solutions

Our company operates to the highest international standards of quality. Our teams are committed to delivering a quality service at each stage of a process from development through to commercial manufacturing, delivering high-quality products at all times.

Quality by Design techniques and the effective use of formal risk management processes are used to define and steer a compliant product strategy that controls and mitigates risk.

Our facilities are regularly inspected by national and international regulatory authorities as well as our clients.

• We operate both classical and lifecycle validation approaches following FDA guidelines.
• Our focus is on Expediting product filings through the registration batch approach.
• Services supported by Product quality risk assessments.
• Strict procedures support Document control both in issuance and through robust archival policies.

Our policies support our clients' active involvement to ensure that no risk occurs in the process of bringing new drugs to market. 

Our highly experienced team can offer complete API regulatory support from initial submission to market authorization:

• We have extensive experience in the preparation and submission of:
  • DMFs for EU/US and several other countries and continents.
  • EP-Certificate of Suitability (CEP).
• Our team also helps our clients in post-approval support activities, including update and variation changes of DMFs & CEPs.
• Our flexible approach in addressing our clients' needs has resulted in many successes and is focused on continuing this track record.